Truist Financial Corp Sells 5,932 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Truist Financial Corp decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,395 shares of the medical instruments supplier’s stock after selling 5,932 shares during the quarter. Truist Financial Corp’s holdings in DENTSPLY SIRONA were worth $533,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Brandes Investment Partners LP increased its holdings in shares of DENTSPLY SIRONA by 102.7% during the second quarter. Brandes Investment Partners LP now owns 46,638 shares of the medical instruments supplier’s stock valued at $1,166,000 after acquiring an additional 23,626 shares in the last quarter. Creative Planning increased its holdings in shares of DENTSPLY SIRONA by 53.9% during the second quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock valued at $412,000 after acquiring an additional 5,793 shares in the last quarter. Algert Global LLC increased its holdings in shares of DENTSPLY SIRONA by 123.9% during the second quarter. Algert Global LLC now owns 32,083 shares of the medical instruments supplier’s stock valued at $799,000 after acquiring an additional 17,753 shares in the last quarter. Scientech Research LLC bought a new stake in shares of DENTSPLY SIRONA during the second quarter valued at approximately $846,000. Finally, Mackenzie Financial Corp increased its holdings in shares of DENTSPLY SIRONA by 14.1% during the second quarter. Mackenzie Financial Corp now owns 101,876 shares of the medical instruments supplier’s stock valued at $2,538,000 after acquiring an additional 12,578 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on XRAY. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Evercore ISI cut their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and an average price target of $33.22.

DENTSPLY SIRONA Stock Up 1.4 %

XRAY stock opened at $24.64 on Thursday. The stock’s fifty day simple moving average is $25.27 and its two-hundred day simple moving average is $26.88. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a 1-year low of $23.58 and a 1-year high of $37.60. The stock has a market cap of $4.99 billion, a P/E ratio of -28.65, a P/E/G ratio of 1.17 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. During the same period in the prior year, the firm posted $0.51 EPS. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. Analysts expect that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.60%. DENTSPLY SIRONA’s payout ratio is presently -74.42%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.